Publications

  1. Gupta S, Kosari F, Thapa P, Murphy SJ, Johnson SH, Greipp PT, Dashti NK, Tekin B, Zarka JG, Dasari S, Kipp BR, Sharma V, Shah PH, Orme JJ, Frank I, Karnes RJ, Boorjian SA, Vasmatzis G, Cheville JC. Sarcomatoid urothelial carcinoma with constitutive PD-L1 overexpression. Am J Clin Pathol. 2026 Apr 3; 165 (4)
    View PubMed
  2. Roberson DS, Basourakos SP, Cheville JC, Lopez CAR, Singla N, Shapiro DD, Abel EJ, Dorr M, Henning GM, McLeay Ii MT, Khanna A, Costello BA, Boorjian SA, Leibovich BC, Sharma V. A Simplified Prediction Tool for Metastasis After Nephrectomy With Venous Tumor Thrombectomy for RCC. Urology. 2026 Apr; 210:91-96 Epub 2026 Feb 03
    View PubMed
  3. Qosja N, Denic A, Kukla A, Mullan AF, Sharma V, Kline TL, Rule AD, Geldmaker LE, Thiel DD. Evaluating the Association of Nontumor Kidney Perirenal Fat Characteristics With Long-Term Renal Function and Mortality After Radical Nephrectomy. Mayo Clin Proc. 2026 Mar 31 [Epub ahead of print]
    View PubMed
  4. Tucker J, Sharma V, Johnson M, Hibbert R, Kapplinger J, Moynagh M, Adamo D, Schmitz J, Parvinian A. Safety and Diagnostic Yield of Percutaneous Urinary Bladder Tumor Biopsy. Abdom Radiol (NY). 2026 Mar; 51 (3):1444-1449 Epub 2025 July 28
    View PubMed
  5. Grier AL, Zhong JY, Basourakos S, Calaway A, Singh P, Zakharia Y, Lucien F, Karnes RJ, Sharma V, Shah P, Costello BA, Pagliaro LC, Orme JJ, Brown JR, Jang A. Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder Cancer. Cancers (Basel). 2026 Feb 14; 18 (4)
    View PubMed
  6. McCarthy M, Wojcik AA, Barr Fritcher EG, Tekin B, Shen W, Al-Kateb H, Dasari S, Lucas PC, Ebare K, Reynolds JP, Stanton ML, Raghunathan A, Whaley RD, Erickson LA, Hernandez LH, Jimenez RE, Costello BA, Potretzke A, Boorjian SA, Sharma V, Leibovich BC, Cheville JC, Kipp BR, Gupta S. Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency). Mayo Clin Proc. 2026 Feb 12. [Epub ahead of print]
    View PubMed
  7. Cheville JC, Orme JJ, Gupta S, Lucien-Matteoni F, Karnes RJ, Thapa P, Khanna A, Naik S, Sharma V, Frank I, Pagliaro L, Quevedo F, Tekin B, Knudson R, Greipp P, Brandt C, Koepplin J, Costello B, Heath E, Vasmatzis G, Florio A, Boorjian SA, Shah PH. Defining NECTIN4 Amplification and Protein Expression in Urothelial Carcinoma and Histologic Subtypes. Mod Pathol. 2026 Jan; 39 (1):100928 Epub 2025 Oct 29
    View PubMed
  8. McLeay MT 2nd, Roberson DS, Dorr M, Morales-Martinez GA, Basourakos SP, Kline TL, Cheville J, Khanna A, Potretzke TA, Boorjian SA, Leibovich BC, Sharma V. Growth Kinetics of Venous Tumor Thrombus From Renal Cell Carcinoma. J Urol. 2025 Dec; 214 (6):601-612 Epub 2025 Aug 26
    View PubMed
  9. Mangalaparthi KK, Sachdeva GS, Shaik AA, Venkataraman S, Mullan AF, Pujari GP, Madden BJ, Asghar MS, Sharma V, Alexander MP, Larson NB, Denic A, Pandey A, Rule AD. Spatial Mass Spectrometry-Based Proteomic Analysis of Normal-Appearing Glomeruli from Young and Old Adults. Kidney360. 2025 Dec 1; 6 (12):2071-2081 Epub 2025 Sept 30
    View PubMed
  10. Winter TD, Jahagirdar O, Johansson M, Brennan P, Machiela MJ, Chanock SJ, Purdue MP, Dutta D, Renal Cancer Genetics Consortium. Using Mendelian randomization to investigate etiologic heterogeneity across renal cell carcinoma subtypes. Int J Epidemiol. 2025 Oct 14; 54 (6)
    View PubMed
  11. Mun DG, Pujari GP, Sachdeva G, Madden BJ, Charlesworth MC, Johnson KL, Archila LR, Alexander MP, Denic A, Mullan AF, Sharma V, Larson NB, Luehrs AC, Rule AD, Pandey A. Spatial proteomics to discover aging-associated alterations in the renal tubulointerstitium. Clin Proteomics. 2025 Oct 08; 22(1):37.
    View PubMed
  12. Powell C, Day C, Sharma V, van Buskirk C, Warner MA, Habermann EB, Houdek M, Taner T, Heimbach J, Thiels C. Oncologic Outcomes of Intraoperative Autologous Blood Transfusion for Major Oncologic Resection. Ann Surg Oncol. 2025 Oct; 32 (10):7644-7651 Epub 2025 Aug 17
    View PubMed
  13. Roberson DS, McLeay MT 2nd, Henning G, Morales-Martinez G, Thapa P, Khanna A, Frank I, Tollefson MK, Shah P, Karnes RJ, Boorjian SA, Sharma V. The impact of prophylactic incisional negative pressure wound therapy on surgical site infection following open radical cystectomy. Urol Oncol. 2025 Oct; 43 (10):586-593 Epub 2025 Aug 11
    View PubMed
  14. Henning GM, Deol ES, Vasdev R, Basourakos SP, Roberson DS, McLeay MT, Khanna A, Boorjian SA, Leibovich BC, Sharma V. Characterizing the Hospital Caseload-Outcome Relationship for Radical Nephrectomy With Inferior Vena Cava Tumor Thrombectomy: Analysis From the National Inpatient Sample. Urology. 2025 Oct; 204:96-102 Epub 2025 May 30
    View PubMed
  15. Denic A, Shaik AA, Fareeduddin SK, Fnu A, Kumar M, Mullan AF, Sharma V, Alexander MP, Pandey A, Wiggins RC, Hodgin JB, Shankland SJ, Rule AD. Lower Podocyte Number per Glomerulus Associates With Progressive CKD. Kidney Int Rep. 2025 Sep; 10 (9):3213-3224 Epub 2025 June 11
    View PubMed
  16. Fadel A, Findlay BL, Pinkhasov AM, Sharma V, Anderson KT, Viers BR. Variability in Health Care Utilization and Perioperative Outcomes Among Urinary Diversion Patients: Analysis of the National Surgical Quality Improvement Program Database. Urol Pract. 2025 Sep; 12 (5):548-556 Epub 2025 May 27
    View PubMed
  17. Gupta S, Dasari S, Warren RR, Shen W, Urban RM, Stanton ML, Lohse CM, Holdren MA, Hoenig MF, Pitel BA, Smoley SA, Nelson SW, Torell NR, Moon AC, Nelson LM, Garcia JJ, Lucas PC, Halling KC, Kipp BR, Boorjian SA, De Langhe SP, Erickson LA, Sharma V, Cheville JC, Leibovich BC. Renal Neoplasia in Birt-Hogg-Dube Syndrome: Integrated Histopathologic, Bulk, and Single-cell Transcriptomic Analysis. Eur Urol. 2025 Sep; 88 (3):263-273 Epub 2025 Apr 18
    View PubMed
  18. Roberson DS, Sharma V, Boorjian SA, McLeay MT 2nd, Reitano G, Nguyen MV, Orme JJ, Childs DS, Pagliaro LC, Potretzke AM, Karnes RJ, Shah P, Zganjar A, Lyon T, Tyson MD, Khanna A. Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter Analysis. Eur Urol 2025 Aug; 88 (2):212-214 Epub 2025 May 26
    View PubMed
  19. Zhang JH, Joyce DD, Shan Y, Fadel A, Liao B, Boorjian SA, Chamie K, Williams SB, Sharma V. National complication and cost burden of transurethral resection of bladder tumor for bladder cancer. Urol Oncol. 2025 Aug; 43 (8):469.e1-469.e11 Epub 2025 Apr 23
    View PubMed
  20. Roberson DS, Boorjian SA, Sharma V, Leibovich BC. Level setting: a history and illustrative clarification of the Mayo Clinic tumour thrombus levels. BJU Int. 2025 Jul; 136 (1):32-34 Epub 2025 Mar 31
    View PubMed
  21. Lee MS, Moschini M, Britton CJ, Longoni M, Tarrell RF, Martin AJ, Traughber BJ, Stish BJ, Orme JJ, Shah PH, Frank I, Jeffrey Karnes R, Boorjian SA, Sharma V. Development and external validation of a local pelvic recurrence risk score after radical cystectomy: identifying the ideal candidate for adjuvant radiation clinical trials. Urology. 2025 Jun 15 Epub 2025 June 15
    View PubMed
  22. Joyce DD, Wymer KM, Graves JA, Boorjian SA, Gore JL, Khaki AR, Raldow AC, Williams SB, Smith AB, Sharma V. Cost-Effectiveness of Trimodal Therapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer. JAMA Netw Open. 2025 Jun 2; 8 (6):e2517056 Epub 2025 June 02
    View PubMed
  23. Henning GM, Deol ES, Vasdev RM, Basourakos SP, Yang DY, Tollefson MK, Frank I, Shah P, Khanna A, Karnes RJ, Boorjian SA, Sharma V. Trends in Outpatient Radical Prostatectomy and Same-Day Discharge for Prostate Cancer: Analysis of the National Inpatient Sample and Nationwide Ambulatory Surgery Sample. Urol Pract. 2025 May; 12 (3):305-315 Epub 2025 Feb 04
    View PubMed
  24. Khanna A, Wolf T, Frank I, Krueger A, Shah P, Sharma V, Gettman MT, Boorjian SA, Asselmann D, Tollefson MK. Enhancing Accuracy of Operative Reports with Automated Artificial Intelligence Analysis of Surgical Video. J Am Coll Surg. 2025 May 1; 240 (5):739-746 Epub 2025 Apr 16
    View PubMed
  25. Whaley RD, Sill DR, Tekin B, McCarthy MR, Cheville JC, Ebare K, Stanton ML, Reynolds JP, Raghunathan A, Herrera Hernandez LP, Jimenez RE, Sharma V, Boorjian SA, Leibovich BC, Hofich CD, Alvand S, Pujari GP, Kipp BR, Ketterling RP, Geiersbach KB, Greipp PT, Sukov WR, Halling KC, Gupta S. Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistry. Hum Pathol. 2025 May; 159:105797 Epub 2025 May 15
    View PubMed
  26. Tekin B, Cheville JC, Milosevic D, McCarthy M, Whaley RD, Hernandez LH, Jimenez RE, Sharma V, Leibovich BC, Boorjian SA, Costello BA, Pagliaro LC, Gupta S. Assessment of trophoblast cell-surface antigen 2 (TROP2) and nectin-4 expression in choriocarcinoma. Hum Pathol. 2025 May; 159:105815 Epub 2025 May 23
    View PubMed
  27. Deol ES, Lehner KS, Fadel AE, Rangel LJ, Khanna A, Tollefson MK, Shah PH, Frank I, Boorjian SA, Karnes RJ, Sharma V. Impact of obesity on prostatectomy outcomes: Insights from a large prospectively maintained cohort. Urol Oncol. 2025 May; 43 (5):334.e7-334.e15 Epub 2025 Apr 05
    View PubMed
  28. Cohen EP, Denic A, Aperna F, Mullan AF, Barisoni L, Sharma V, Gibson IW, Rule AD. Stenosis of the glomerulotubular neck in progressive chronic kidney disease. Nephrol Dial Transplant. 2025 Apr 28; 40 (5):917-928
    View PubMed
  29. Nabavizadeh R, Rodrigues Pessoa R, Cheville JC, Lohse CM, Costello BA, Lucien F, Thompson RH, Boorjian SA, Leibovich BC, Sharma V. Renal Cell Carcinoma With Venous Tumor Thrombus Has a Predilection for the Lungs. Urology. 2025 Apr; 198:68-74 Epub 2024 Dec 27
    View PubMed
  30. Martin A, Mahmoud AM, Britton CJ, Fadel A, Ahmed ME, Sharma V, Childs DS, Johnson GB, Davis BJ, Mynderse L, Lomas D, Woodrum D, Frendl D, Karnes JR, Tollefson MK, Kwon ED, Andrews JR. In-field prostate cancer recurrence following radical prostatectomy and salvage radiation. BJU Int. 2025 Apr; 135 (4):668-674 Epub 2024 Nov 30
    View PubMed
  31. Ahmed ME, Andrews JR, Mahmoud AM, Reitano G, Thapa P, Tyson MD, Khanna A, Shah P, Sharma V, Thompson RH, Boorjian SA, Frank I, Tollefson MK, Karnes RJ. Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival Outcomes. J Urol. 2025 Apr; 213 (4):447-454 Epub 2024 Dec 02
    View PubMed
  32. Sharma V, Fadel A, Tollefson MK, Psutka SP, Blezek DJ, Frank I, Thapa P, Tarrell R, Viers LD, Potretzke AM, Hartman RP, Boorjian SA, Viers BR. Artificial Intelligence-Based Assessment of Preoperative Body Composition Is Associated With Early Complications After Radical Cystectomy. J Urol. 2025 Feb; 213 (2):228-237 Epub 2024 Oct 11
    View PubMed
  33. Bock J, Sharma V, Jundt M, Bendel E, Thompson S. Treatment of a high-volume retroperitoneal lymphocele with obstructive hydronephrosis following lymph node dissection via combined intra-lymphocele retrograde lymphangiography with glue embolization and sclerotherapy. Urol Case Rep. 2025 Jan; 58:102895 Epub 2024 Nov 28
    View PubMed
  34. Rodrigues Pessoa R, Nabavizadeh R, Shah P, Frank I, Tollefson M, Sharma V, Rangel LJ, Cheville JC, Karnes RJ, Boorjian SA. Relative impact of lymph-node metastasis and seminal vesical invasion on oncologic outcomes following radical prostatectomy. Prostate Cancer Prostatic Dis. 2024 Dec; 27 (4):674-679 Epub 2023 Sept 15
    View PubMed
  35. Britton CJ, Sharma V, Zganjar A, Lohse CM, Cheville JC, Houston Thompson R, Leibovich BC, Boorjian SA, Potretzke AM. Evaluation of American Urological Association Renal Cell Carcinoma Risk Groups for Chromophobe Renal Cell Carcinoma. Urology. 2024 Dec; 194:138-143 Epub 2024 Aug 10
    View PubMed
  36. Deol ES, Sharma V, Fadel AE, Vasdev R, Henning G, Basourakos S, Ghaffar U, Tollefson MK, Frank I, Houston Thompson R, Karnes RJ, Boorjian SA, Khanna A. Comparing Frailty Indices for Risk Stratification in Urologic Oncology: Which Index to Choose? Urology. 2024 Dec; 194:154-161 Epub 2024 Aug 28
    View PubMed
  37. Deol ES, Jefferson FA, Fadel AE, Sharma V, Blezek DJ, Elliott DS, Viers BR, Linder BJ. Evaluating the impact of artificial intelligence-based assessment of body composition on primary artificial urinary sphincter placement outcomes. Transl Androl Urol. 2024 Oct 31; 13 (10):2238-2245 Epub 2024 Oct 28
    View PubMed
  38. Khanna A, Gottlich HC, Dorr M, Lohse CM, Zganjar A, Sharma V, Joyce D, Potretzke A, Britton C, Rule AD, Boorjian SA, Leibovich BC, Thompson RH. Reply by Authors. J Urol 2024 Oct; 212 (4):559 Epub 2024 July 30
    View PubMed
  39. Sharma V. Reply: Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma. J Urol 2024 Oct; 212 (4):621-622 Epub 2024 July 08
    View PubMed
  40. Khanna A, Gottlich HC, Dorr M, Lohse CM, Zganjar A, Sharma V, Joyce D, Potretzke A, Britton C, Rule AD, Boorjian SA, Leibovich BC, Thompson RH. End-Stage Kidney Disease After Partial and Radical Nephrectomy Among Patients With Severe Chronic Kidney Disease. J Urol. 2024 Oct; 212 (4):550-559 Epub 2024 June 27
    View PubMed
  41. Britton CJ, Sharma V, Lohse CM, Potretzke AM, Boorjian SA, Thompson RH, Cheville JC, Leibovich BC. Incidence and predictors of ipsilateral local recurrence following partial nephrectomy. Urol Oncol. 2024 Oct; 42 (10):334.e1-334.e9 Epub 2024 June 29
    View PubMed
  42. Salehinejad H, Muaddi H, Ubl DS, Sharma V, Thiels CA. Deep learning predicts postoperative opioids refills in a multi-institutional cohort of surgical patients. Surgery. 2024 Aug; 176 (2):246-251 Epub 2024 May 25
    View PubMed
  43. Zganjar A, Khanna A, Joyce D, Nichols P, Britton C, Lohse CM, Cheville JC, Gupta S, Potretzke AM, Thompson RH, Leibovich BC, Boorjian SA, Sharma V. Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma. J Urol. 2024 Aug; 212 (2):331-341 Epub 2024 May 30
    View PubMed
  44. Zganjar A, Khanna A, Joyce D, Nichols P, Britton C, Lohse CM, Cheville JC, Gupta S, Potretzke AM, Thompson RH, Leibovich BC, Boorjian SA, Sharma V. Reply by Authors. J Urol 2024 Aug; 212 (2):341 Epub 2024 May 30
    View PubMed
  45. Deol ES, Henning G, Basourakos S, Vasdev RMS, Sharma V, Kavoussi NL, Karnes RJ, Leibovich BC, Boorjian SA, Khanna A. Artificial intelligence model for automated surgical instrument detection and counting: an experimental proof-of-concept study. Patient Saf Surg. 2024 Jul 21; 18 (1):24 Epub 2024 July 21
    View PubMed
  46. Sabov M, Denic A, Mullan AF, Luehrs AC, Kline TL, Erickson BJ, Potretzke TA, Thompson RH, Sharma V, Harris PC, Rule AD. Association of Kidney Cysts With Progressive CKD After Radical Nephrectomy. Am J Kidney Dis. 2024 Jul; 84 (1):62-72.e1 Epub 2024 Jan 26
    View PubMed
  47. Gulati R, Jiao B, Al-Faouri R, Sharma V, Kaul S, Fleishman A, Wymer K, Boorjian SA, Olumi AF, Etzioni R, Gershman B. Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model Analysis. Ann Intern Med. 2024 Jul; 177 (7):871-881 Epub 2024 June 04
    View PubMed
  48. Joyce DD, Boehmer KR, Kamath CC, LaVecchia CM, Sharma V, Schulte PJ, Tilburt JC, Penson DF, Boorjian SA. Financial Toxicity Among Patients With Metastatic Prostate Cancer: A Mixed Methods Approach to Identify Effective Interventions. Urol Pract. 2024 Jul; 11 (4):640-652 Epub 2024 May 09
    View PubMed
  49. Purdue MP, Dutta D, Machiela MJ, Gorman BR, Winter T, Okuhara D, Cleland S, Ferreiro-Iglesias A, Scheet P, Liu A, Wu C, Antwi SO, Larkin J, Zequi SC, Sun M, Hikino K, Hajiran A, Lawson KA, Carcano F, Blanchet O, Shuch B, Nepple KG, Margue G, Sundi D, Diver WR, Folgueira MAAK, van Bokhoven A, Neffa F, Brown KM, Hofmann JN, Rhee J, Yeager M, Cole NR, Hicks BD, Manning MR, Hutchinson AA, Rothman N, Huang WY, Linehan WM, Lori A, Ferragu M, Zidane-Marinnes M, Serrano SV, Magnabosco WJ, Vilas A, Decia R, Carusso F, Graham LS, Anderson K, Bilen MA, Arciero C, Pellegrin I, Ricard S, Scelo G, Banks RE, Vasudev NS, Soomro N, Stewart GD, Adeyoju A, Bromage S, Hrouda D, Gibbons N, Patel P, Sullivan M, Protheroe A, Nugent FI, Fournier MJ, Zhang X, Martin LJ, Komisarenko M, Eisen T, Cunningham SA, Connolly DC, Uzzo RG, Zaridze D, Mukeria A, Holcatova I, Hornakova A, Foretova L, Janout V, Mates D, Jinga V, Rascu S, Mijuskovic M, Savic S, Milosavljevic S, Gaborieau V, Abedi-Ardekani B, McKay J, Johansson M, Phouthavongsy L, Hayman L, Li J, Lungu I, Bezerra SM, Souza AG, Sares CTG, Reis RB, Gallucci FP, Cordeiro MD, Pomerantz M, Lee GM, Freedman ML, Jeong A, Greenberg SE, Sanchez A, Thompson RH, Sharma V, Thiel DD, Ball CT, Abreu D, Lam ET, Nahas WC, Master VA, Patel AV, Bernhard JC, Freedman ND, Bigot P, Reis RM, Colli LM, Finelli A, Manley BJ, Terao C, Choueiri TK, Carraro DM, Houlston R, Eckel-Passow JE, Abbosh PH, Ganna A, Brennan P, Gu J, Chanock SJ, BioBank Japan Project//FinnGen. Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet. 2024 May; 56 (5):809-818 Epub 2024 Apr 26
    View PubMed
  50. Gupta S, Dasari S, Sharma V, Atwell TD, Sivasankaran G, Smoley SA, Hardcastle JJ, Lohse CM, Tekin B, Jimenez RE, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC. Metastatic clear cell papillary renal cell 'tumour'. Histopathology 2024 Apr; 84 (5):905-909 Epub 2023 Dec 26
    View PubMed
  51. Khanna A, Antolin A, Bar O, Ben-Ayoun D, Zohar M, Boorjian SA, Frank I, Shah P, Sharma V, Thompson RH, Wolf T, Asselmann D, Tollefson M. Automated Identification of Key Steps in Robotic-Assisted Radical Prostatectomy Using Artificial Intelligence. J Urol. 2024 Apr; 211 (4):575-584 Epub 2024 Jan 24
    View PubMed
  52. Campbell RA, Khanna A, Boorjian SA, Knorr J, Cox R, Nicholas M, Cheville J, Sharma V, Murthy PB, Tarrell R, Thapa P, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Haber GP, Lee B. Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With Variant Histology Undergoing Radical Cystectomy. Clin Genitourin Cancer. 2024 Apr; 22 (2):157-163.e1 Epub 2023 Oct 26
    View PubMed
  53. Nielson KJ, Rowsey R, Dasari S, Sukov WR, Kipp BR, Raghunathan A, Whaley RD, Ebare K, Stanton ML, Reynolds JP, Sharma V, Thompson RH, Boorjian SA, Leibovich BC, Hernandez LH, Jimenez RE, Cheville JC, Gupta S. Single nucleotide polymorphism (SNP) chromosomal microarray as a diagnostic tool for mucinous tubular and spindle cell carcinoma: A validation study. Hum Pathol. 2024 Apr; 146:57-65 Epub 2024 Apr 12
    View PubMed
  54. Joyce DD, Sharma V, Wymer KM, Moriarty JP, Borah BJ, Walia A, Costello BA, Pagliaro LC, Daneshmand S, Leibovich BC, Boorjian SA. Comparative cost-effectiveness of contemporary treatment strategies for stage IIA seminoma. J Natl Cancer Inst. 2024 Mar 7; 116 (3):468-475
    View PubMed
  55. Joyce DD, Shan Y, Stewart CA, Chamie K, Galsky MD, Boorjian SA, Williams SB, Sharma V. A SEER-Medicare Based Quality Score for Patients With Metastatic Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer. 2024 Feb; 22 (1):14-22 Epub 2023 June 22
    View PubMed
  56. Wymer KM, Thao V, Narang G, Sharma V, Borah BJ, Cheney S, Humphreys MR. Evaluation of Private Payer and Patient Out-of-Pocket Costs Associated With the Surgical Management of Benign Prostatic Hyperplasia. Urology. 2024 Feb; 184:87-93 Epub 2023 Dec 06
    View PubMed
  57. Mian AH, Tollefson MK, Shah P, Sharma V, Mian A, Thompson RH, Boorjian SA, Frank I, Khanna A. Navigating Now and Next: Recent Advances and Future Horizons in Robotic Radical Prostatectomy. J Clin Med. 2024 Jan 9; 13 (2) Epub 2024 Jan 09
    View PubMed
  58. Nabavizadeh R, Rodrigues Pessoa R, Dumbrava MG, Packiam VT, Thapa P, Tarrell R, Tollefson MK, Jeffrey Karnes R, Frank I, Khanna A, Shah P, Sharma V, Boorjian SA. Cutaneous Ureterostomy Following Radical Cystectomy for Bladder Cancer: A Contemporary Series. Urology. 2023 Nov; 181:162-166 Epub 2023 Sept 07
    View PubMed
  59. Pessoa RR, Nabavizadeh R, Quevedo F, Joyce DD, Lohse CM, Sharma V, Costello BA, Boorjian SA, Thompson RH, Leibovich BC, Cheville JC. The Impact of Metastasis Histopathology on Oncologic Outcomes for Patients With Surgically Resected Metastatic Renal Cell Carcinoma. J Urol. 2023 Oct; 210 (4):611-618 Epub 2023 June 20
    View PubMed
  60. Joyce DD, Qin X, Sharma V, Boorjian SA, Barocas DA, Dusetzina SB, Moses KA. The Impact of Medicare Low-income Subsidy on Access to Treatment, Treatment Choice, and Oncologic Outcomes in Patients With Metastatic Prostate Cancer. J Urol. 2023 Sep; 210 (3):447-453 Epub 2023 June 21
    View PubMed
  61. Roshandel MR, Lohse CM, Sharma V, Thompson RH, Boorjian SA, Leibovich BC. Implications of Tumor Surgery in Horseshoe Kidneys: A Comparative Study of Outcomes and Surgical Practices. Urology. 2023 Sep; 179:87-94 Epub 2023 June 17
    View PubMed
  62. Joyce DD, Schulte PJ, Kwon ED, Dusetzina SB, Moses KA, Sharma V, Penson DF, Tilburt JC, Boorjian SA. Coping Mechanisms for Financial Toxicity Among Patients With Metastatic Prostate Cancer: A Survey-based Assessment. J Urol. 2023 Aug; 210 (2):290-298 Epub 2023 July 07
    View PubMed
  63. Gottlich HC, Gregory AV, Sharma V, Khanna A, Moustafa AU, Lohse CM, Potretzke TA, Korfiatis P, Potretzke AM, Denic A, Rule AD, Takahashi N, Erickson BJ, Leibovich BC, Kline TL. Effect of Dataset Size and Medical Image Modality on Convolutional Neural Network Model Performance for Automated Segmentation: A CT and MR Renal Tumor Imaging Study. J Digit Imaging. 2023 Aug; 36 (4):1770-1781 Epub 2023 Mar 17
    View PubMed
  64. Britton CJ, Sharma V, Fadel AE, Bearrick E, Findlay BL, Frank I, Tollefson MK, Karnes RJ, Viers BR. Vesicourethral Anastomotic Stenosis Following Radical Prostatectomy: Risk Factors, Natural History, and Treatment Outcomes. J Urol. 2023 Aug; 210 (2):312-322 Epub 2023 Apr 20
    View PubMed
  65. Denic A, Mullan AF, Alexander MP, Wilson LD, Augustine J, Luehrs AC, Stegall MD, Kline TL, Sharma V, Thompson RH, Rule AD. An Improved Method for Estimating Nephron Number and the Association of Resulting Nephron Number Estimates with Chronic Kidney Disease Outcomes. J Am Soc Nephrol. 2023 Jul 01; 34(7):1264-1278. Epub 2023 Mar 23.
    View PubMed
  66. Joyce DD, Sharma V, Williams SB. Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the Literature. Pharmacoeconomics. 2023 Jul; 41 (7):751-769 Epub 2023 Apr 23
    View PubMed
  67. McCarthy MR, Nichols PE, Sharma V, Stanton ML, Reynolds JP, Pitel BA, Halling KC, Lohse CM, Herrera-Hernandez L, Thompson RH, Leibovich BC, Jimenez RE, Boorjian SA, Cheville JC, Gupta S. Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1, and ATRX. Arch Pathol Lab Med. 2023 Jul 01; 147(7):817-825.
    View PubMed
  68. An Z, Hsu MA, Gicobi JK, Xu T, Harrington SM, Zhang H, Pavelko KD, Hirdler JB, Lohse CM, Nabavizadeh R, Pessoa RR, Sharma V, Thompson RH, Leibovich BC, Dong H, Lucien F. A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma. J Immunol. 2023 Jun 15; 210 (12):2029-2037
    View PubMed
  69. Britton CJ, Sharma V, Lohse CM, Thompson RH, Lieske JC, Rule AD, Potretzke AM. Non-race-based Glomerular Filtration Rates to Estimate Renal Functional Outcomes Following Radical and Partial Nephrectomy. Urol Pract 2023 May; 10 (3):213-216 Epub 2023 Jan 24
    View PubMed
  70. Britton CJ, Sharma V, Lohse CM, Thompson RH, Lieske JC, Rule AD, Potretzke AM. Reply by Authors. Urol Pract. 2023 May; 10 (3):216 Epub 2023 Mar 09
    View PubMed
  71. Sharma V, Chamie K, Schoenberg M, Lee VS, Fero K, Lec P, Munneke JR, Aaronson DS, Kushi LH, Quesenberry CP, Tang L, Kwan ML. Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective Cohort. Urology. 2023 Mar; 173:134-141 Epub 2022 Dec 24
    View PubMed
  72. Mertens LS, Sharma V, Matin SF, Boorjian SA, Houston Thompson R, van Rhijn BWG, Masson-Lecomte A. Bladder Recurrence Following Upper Tract Surgery for Urothelial Carcinoma: A Contemporary Review of Risk Factors and Management Strategies. Eur Urol Open Sci. 2023 Mar; 49:60-66 Epub 2023 Jan 28
    View PubMed
  73. Britton CJ, Andrews JR, Wallis CJD, Sharma V, Leibovich BC, Thompson RH, Boorjian SA, Bhindi B, Costello BA. Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis. Urol Oncol. 2023 Mar; 41 (3):125-136 Epub 2022 Oct 28
    View PubMed
  74. Lyon TD, Roussel E, Sharma V, Carames G, Lohse CM, Costello BA, Boorjian SA, Thompson RH, Joniau S, Albersen M, Leibovich BC. International Multi-institutional Characterization of the Perioperative Morbidity of Metastasectomy for Renal Cell Carcinoma. Eur Urol Oncol. 2023 Feb; 6 (1):76-83 Epub 2022 Dec 09
    View PubMed
  75. Britton CJ, Gottlich HC, Tarrell RF, Thapa P, Joyce DD, Shah PH, Sharma V, Boorjian SA, Frank I, Potretzke AM. Perioperative and Oncologic Outcomes Associated with Simultaneous Radical Cystectomy and Nephroureterectomy. Urology. 2023 Feb; 172:149-156 Epub 2022 Nov 25
    View PubMed
  76. Potretzke A, Britton CJ, Sharma V, Lohse CM, Thompson R, Lieske JC, Rule AD. Non-race-based Glomerular Filtration Rates to Estimate Renal Functional Outcomes Following Nephrectomy AUA Journal. 2023.
  77. Wymer KM, Narang G, Slade A, Sharma V, Thao V, Borah BJ, Rivera M, Cheney S, Humphreys MR. Evaluation of the Cost-Effectiveness of Surgical Treatment Options for Benign Prostatic Hyperplasia. Urology. 2023 Jan; 171:96-102 Epub 2022 Oct 19
    View PubMed
  78. Sharma V, Wymer KM, Joyce DD, Moriarty J, Khanna A, Borah BJ, Thompson RH, Costello BA, Leibovich BC, Boorjian SA. Cost-effectiveness of Adjuvant Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Insights for Patient Selection From a Markov Model. J Urol. 2023 Jan; 209 (1):89-98 Epub 2022 Sept 06
    View PubMed
  79. Joyce DD, Wymer KM, Sharma V, Moriarty JP, Borah BJ, Geynisman DM, Plimack ER, Costello BA, Pagliaro LC, Boorjian SA. Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data. Cancer. 2022 Dec 15; 128 (24):4194-4202 Epub 2022 Oct 17
    View PubMed
  80. Andrews JR, Ahmed ME, Sharma V, Britton C, Stish B, Phillips R, Kendi AT, Joshi VB, Sood A, Tollefson MK, Boorjian SA, Karnes RJ, Kwon ED. Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer. J Urol. 2022 Dec; 208(6):1240-1249. Epub 2022 Nov 09.
    View PubMed
  81. Britton CJ, Sharma V, Lohse CM, Lieske JC, Nichols PE, Khanna A, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH, Potretzke AM. Progression of Chronic Kidney Disease Following Radical and Partial Nephrectomy. Urology. 2022 Nov; 169:125-133 Epub 2022 July 22
    View PubMed
  82. Tsivian M, Joyce DD, Packiam VT, Lohse CM, Boorjian SA, Potretzke TA, Chow GK, Leibovich BC, Sharma V, Thompson RH. Unplanned Conversion From Partial to Radical Nephrectomy: An Analysis of Incidence, Etiology, and Risk Factors. J Urol. 2022 Nov; 208 (5):960-968 Epub 2022 June 24
    View PubMed
  83. Gupta S, Nichols P, Lohse CM, Kosari F, Kattah AG, Harris FR, Karagouga G, Mehra R, Fine SW, Reuter VE, Herrera-Hernandez L, Zganjar AJ, Britton CJ, Potretzke AM, Boorjian SA, Thompson RH, Jimenez RE, Leibovich BC, Garovic VD, Cheville JC, Sharma V. Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors. Mayo Clin Proc. 2022 Nov; 97 (11):2050-2064 Epub 2022 June 24
    View PubMed
  84. Joyce DD, Sharma V, Jiang DH, Van Houten HK, Sangaralingham LR, Borah BJ, Kwon ED, Penson DF, Dusetzina SB, Tilburt JC, Boorjian SA. Out-of-Pocket Cost Burden Associated With Contemporary Management of Advanced Prostate Cancer Among Commercially Insured Patients. J Urol. 2022 Nov; 208 (5):987-996 Epub 2022 Sept 12
    View PubMed
  85. Britton CJ, Andrews JR, Wallis , C, Sharma V, Leibovich BC, Thompson R, Boorjian SA, Bhindi , B, Costello BA. Deferred cytoreductive nephrectomy in the management of metastatic renal cell carcinoma: A systematic review and meta-analysis Urologic Oncology. 2022; 41(3):125-36.
  86. Gupta S, Folpe AL, Torres-Mora J, Reuter VE, Zuckerman JE, Falk N, Stanton ML, Muthusamy S, Smith SC, Sharma V, Sethi S, Herrera-Hernandez L, Jimenez RE, Cheville JC. Immunohistochemical expression of renin and GATA3 help distinguish juxtaglomerular cell tumors from renal glomus tumors. Hum Pathol. 2022 Oct; 128:110-123 Epub 2022 Aug 01
    View PubMed
  87. Sharma V. Editorial Comment. J Urol 2022 Sep; 208 (3):597-598 Epub 2022 July 27
    View PubMed
  88. Khanna A, Miest T, Sharma V, Campbell R, Hensley P, Thapa P, Zganjar A, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Murthy PB, Haber GP, Navai N, Kamat AM, Dinney C, Lee B, Boorjian SA. Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience. J Urol. 2022 Mar; 207(3):551-558. Epub 2021 Oct 25.
    View PubMed
  89. Britton CJ, Jefferson FA, Findlay BL, Sharma V, Hernandez JC, Levine LA, Ziegelmann MJ. Surgical Correction of Adult Congenital Penile Curvature: A Systematic Review. J Sex Med. 2022 Feb 1; 19 (2):364-376
    View PubMed
  90. Sharma V. Editorial Comment. J Urol 2022 Jan; 207 (1):125-126 Epub 2021 Oct 01
    View PubMed
  91. Mori K, Sharma V, Comperat EM, Sato S, Laukhtina E, Schuettfort VM, Pradere B, Sari Motlagh R, Mostafaei H, Quhal F, Kardoust Parizi M, Abufaraj M, Karakiewicz PI, Egawa S, Tilki D, Boorjian SA, Shariat SF. Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer. Ann Surg Oncol. 2021 Dec; 28 (13):9179-9187 Epub 2021 June 11
    View PubMed
  92. Mori K, Sharma V, Egawa S, Tilki D, Boorjian SA, Shariat SF. ASO Author Reflections: Is There Any Difference Among Various Gleason Scores Classified as Grade Group 4 Prostate Cancer? Ann Surg Oncol. 2021 Dec; 28 (13):9188-9189 Epub 2021 June 21
    View PubMed
  93. Wymer KM, Sharma V, Juvet T, Klett DE, Borah BJ, Koo K, Rivera M, Agarwal D, Humphreys MR, Potretzke AM. Cost-effectiveness of Retrograde Intrarenal Surgery, Standard and Mini Percutaneous Nephrolithotomy, and Shock Wave Lithotripsy for the Management of 1-2cm Renal Stones. Urology. 2021 Oct; 156:71-77. Epub 2021 Jul 15.
    View PubMed
  94. Sharma V, Miest TS, Chamie K, Matin SF, Boorjian SA, Potretzke AM. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-analysis. Reply. J Urol 2021 Oct; 206 (4):1072 Epub 2021 July 06
    View PubMed
  95. Sharma V, Miest TS, Juvet TS, Toussi A, Packiam V, Chamie K, Matin SF, Boorjian SA, Thompson RH, Frank I, Tollefson MK, Potretzke AM. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis. J Urol. 2021 Sep; 206 (3):558-567 Epub 2021 Apr 28
    View PubMed
  96. Sharma V, Karnes RJ. Re: Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multicentre Study. Eur Urol 2021 Sep; 80 (3):385 Epub 2021 June 24
    View PubMed
  97. Miest TS, Sharma V, Karnes RJ, Boorjian SA, Thompson RH, Frank I, Tollefson MK. Incidence and predictors of occult preoperative deep vein thrombosis at radical cystectomy for urothelial carcinoma. Can Urol Assoc J. 2021 Sep; 15 (9):E471-E475
    View PubMed
  98. Marra G, Calleris G, Alessio P, Oderda M, Palou J, Joniau S, Piechaud T, Smelzo S, Morlacco A, Sharma V, Tilki D, Van der Poel H, Veerman H, Karnes RJ, Gontero P. Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies? Eur Urol Focus. 2021 Jul; 7 (4):807-811 Epub 2020 May 12
    View PubMed
  99. Packiam VT, Labbate CV, Boorjian SA, Tarrell R, Cheville JC, Avulova S, Sharma V, Tsivian M, Adamic B, Mahmoud M, Werntz RP, Smith ND, Karnes RJ, Tollefson MK, Steinberg GD, Frank I. The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysis. Urol Oncol. 2021 Jul; 39 (7):436.e1-436.e8 Epub 2021 Jan 21
    View PubMed
  100. Miest TS, Sharma V, Boeri L, Tollefson MK, Thompson RH, Boorjian SA, Frank I, Karnes RJ. Does Ureteral Stent Drainage Prior to Cystectomy Increase the Risk of Subsequent Upper Tract Urothelial Carcinoma and Ureteral Complications? Urology. 2021 Jul; 153:215-220 Epub 2020 Aug 05
    View PubMed
  101. Boeri L, Sharma V, Kwon E, Stish BJ, Davis BJ, Karnes RJ. Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience. Prostate Cancer Prostatic Dis. 2021 Jun; 24 (2):514-523 Epub 2020 Dec 02
    View PubMed
  102. Ahmed ME, Phillips RM, Sharma V, Davis BJ, Karnes RJ. Oligometastatic prostatic cancer recurrence: role of salvage lymph node dissection (sLND) and radiation therapy-stereotactic body radiation therapy (RT-SBRT). Curr Opin Urol. 2021 May 1; 31 (3):199-205
    View PubMed
  103. Mori K, Sharma V, Comperat EM, Sato S, Laukhtina E, Schuettfort VM, Pradere B, Parizi MK, Karakiewicz PI, Egawa S, Tilki D, Boorjian SA, Shariat SF. Differential prognostic impact of different Gleason patterns in grade group 4 in radical prostatectomy specimens. Eur J Surg Oncol. 2021 May; 47 (5):1172-1178 Epub 2020 Dec 24
    View PubMed
  104. Wymer KM, Sharma V, Saigal CS, Chamie K, Litwin MS, Packiam VT, Mossanen M, Pagliaro LC, Borah BJ, Boorjian SA. Cost-Effectiveness Analysis of Pembrolizumab for Bacillus Calmette-Guerin-Unresponsive Carcinoma In Situ of the Bladder. J Urol. 2021 May; 205 (5):1326-1335 Epub 2020 Dec 21
    View PubMed
  105. Wymer KM, Sharma V, Manka M, Agarwal D, Dodge N, Gettman M, Rivera M. A Serum C-Reactive Protein and Procalcitonin-Based Risk Score to Predict Urinary Infection in Patients with Obstructive Urolithiasis Undergoing Decompression. J Endourol. 2021 Mar; 35 (3):369-375 Epub 2020 Oct 29
    View PubMed
  106. Westerman ME, Maldonado F, Andrews JR, Sharma V, Trost L, Ziegelmann MJ. Intercourse frequency among men presenting to a sexual health clinic: does age matter? Int J Impot Res. 2021 Jan; 33(1):49-54. Epub 2020 Jan 02.
    View PubMed
  107. Kim S, Kokorovic A, Sharma V, Boorjian S, Rendon RA, Bell D, Mason R. Factors predicting early mortality after radical cystectomy for urothelial carcinoma in a contemporary cohort of patients. Can Urol Assoc J. 2020 Dec; 14 (12):E636-E642
    View PubMed
  108. Dess RT, Suresh K, Zelefsky MJ, Freedland SJ, Mahal BA, Cooperberg MR, Davis BJ, Horwitz EM, Terris MK, Amling CL, Aronson WJ, Kane CJ, Jackson WC, Hearn JWD, Deville C, DeWeese TL, Greco S, McNutt TR, Song DY, Sun Y, Mehra R, Kaffenberger SD, Morgan TM, Nguyen PL, Feng FY, Sharma V, Tran PT, Stish BJ, Pisansky TM, Zaorsky NG, Moraes FY, Berlin A, Finelli A, Fossati N, Gandaglia G, Briganti A, Carroll PR, Karnes RJ, Kattan MW, Schipper MJ, Spratt DE. Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate. JAMA Oncol. 2020 Dec 01; 6(12):1912-1920.
    View PubMed
  109. Manka MG, Miller A, Sharma V, Butaney M, Trost L, Ziegelmann M. Discrepancy between Post-Vasectomy Semen Analysis Recommendation and Practice Patterns in the Post-2012 American Urological Association Guideline Era. J Urol. 2020 Dec; 204 (6):1312-1317 Epub 2020 Aug 17
    View PubMed
  110. Kinnaird A, Sharma V, Chuang R, Priester A, Tran E, Barsa DE, Delfin M, Kwan L, Sisk A, Felker E, Marks LS. Risk of Prostate Cancer after a Negative Magnetic Resonance Imaging Guided Biopsy. J Urol. 2020 Dec; 204 (6):1180-1186 Epub 2020 July 02
    View PubMed
  111. Packiam VT, Tsivian M, Avulova S, Sharma V, Tarrell R, Cheville JC, Frank I, Thompson RH, Tollefson MK, Gettman MT, Karnes RJ, Thapa P, Boorjian SA. Long-term outcomes of incidental prostate cancer at radical cystectomy. Urol Oncol. 2020 Nov; 38 (11):848.e17-848.e22 Epub 2020 July 02
    View PubMed
  112. Lec PM, Lenis AT, Brisbane W, Sharma V, Golla V, Gollapudi K, Blumberg J, Drakaki A, Bergman J, Chamie K. Trends in palliative care interventions among patients with advanced bladder, prostate, or kidney cancer: A retrospective cohort study. Urol Oncol. 2020 Nov; 38 (11):854.e1-854.e9 Epub 2020 May 17
    View PubMed
  113. Lec PM, Venkataramana A, Lenis AT, Fero KE, Sharma V, Golla V, Gollapudi K, Blumberg J, Chamie K. Trends in management of ureteral urothelial carcinoma and effects on survival: a hospital-based registry study. Urol Oncol. 2020 Oct 1 Epub 2020 Oct 01
    View PubMed
  114. Lenis AT, Lec PM, Michel J, Brisbane W, Golla V, Sharma V, Gollapudi K, Blumberg J, Chamie K. Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival. Urol Oncol. 2020 Oct; 38 (10):796.e7-796.e14 Epub 2020 May 20
    View PubMed
  115. Sharma V, Wymer KM, Borah BJ, Saigal CS, Litwin MS, Packiam VT, Thompson RH, Tollefson MK, Karnes RJ, Boorjian SA. Cost-Effectiveness of Maintenance bacillus Calmette-Guerin for Intermediate and High Risk Nonmuscle Invasive Bladder Cancer. J Urol. 2020 Sep; 204 (3):442-449 Epub 2020 Mar 19
    View PubMed
  116. Agarwal DK, Krambeck AE, Sharma V, Maldonado FJ, Westerman ME, Knoedler JJ, Rivera ME. Treatment of non-obstructive, non-struvite urolithiasis is effective in treatment of recurrent urinary tract infections. World J Urol. 2020 Aug; 38(8):2029-2033. Epub 2019 Oct 23.
    View PubMed
  117. Agarwal DK, Sharma V, Toussi A, Viers BR, Tollefson MK, Gettman MT, Frank I. Initial Experience with da Vinci Single-port Robot-assisted Radical Prostatectomies. Eur Urol. 2020 Mar; 77 (3):373-379 Epub 2019 Apr 19
    View PubMed
  118. Sharma V, Karnes RJ, Viers BR. Treatment outcomes of bladder neck contractures from surgical clip erosion: a matched cohort comparison. Transl Androl Urol. 2020 Feb; 9 (1):115-120
    View PubMed
  119. Boeri L, Sharma V, Nehra A, Kwon E, Karnes RJ. The role of salvage lymph node dissection in nonmetastatic castration-resistant prostate cancer: A single center experience. Urol Oncol. 2020 Feb; 38 (2):38.e9-38.e16 Epub 2019 Oct 23
    View PubMed
  120. Joseph JP, Potretzke TA, Packiam V, Sharma V, Toussi A, Miest TS, Juvet T, Boorjian SA, Thompson RH, Welle CL, Atwell TD, Leibovich BC, Tollefson MK, Potretzke AM. Percutaneous Image-guided Core Needle Biopsy for Upper Tract Urothelial Carcinoma. Urology. 2020 Jan; 135:95-100 Epub 2019 Oct 23
    View PubMed
  121. Sharma V, Wymer KM, Borah BJ, Barocas DA, Thompson RH, Karnes RJ, Boorjian SA. Cost-Effectiveness of Active Surveillance, Radical Prostatectomy and External Beam Radiotherapy for Localized Prostate Cancer: An Analysis of the ProtecT Trial. J Urol. 2019 Nov; 202 (5):964-972 Epub 2019 Oct 09
    View PubMed
  122. Westerman ME, Cheville JC, Lohse CM, Sharma V, Boorjian SA, Leibovich BC, Thompson RH. Long-Term Outcomes of Patients With Low Grade Cystic Renal Epithelial Neoplasms. Urology. 2019 Nov; 133:145-150 Epub 2019 July 26
    View PubMed
  123. Gontero P, Marra G, Alessio P, Filippini C, Oderda M, Munoz F, Linares E, Sanchez-Salas R, Challacombe B, Dasgupta P, Goonewardene S, Popert R, Cahill D, Gillatt D, Persad R, Palou J, Joniau S, Piechaud T, Morlacco A, Vidit S, Roupret M, De La Taille A, Albisinni S, Gandaglia G, Mottrie A, Joshi S, Fiscus G, Berger A, Aron M, Van Der Poel H, Tilki D, Lawrentschuk N, Murphy DG, Leung G, Davis J, Karnes RJ, Collaborators. Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches. J Urol. 2019 Oct; 202 (4):725-731 Epub 2019 Sept 06
    View PubMed
  124. Lyon TD, Frank I, Sharma V, Shah PH, Tollefson MK, Thompson RH, Karnes RJ, Thapa P, Cheville JC, Boorjian SA. A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease. World J Urol. 2019 Aug; 37 (8):1605-1613 Epub 2018 Nov 03
    View PubMed
  125. Wymer KM, Sharma V, Davis BJ, Kwon ED, Mynderse LA, Karnes RJ. Evaluating the Potential Role of Salvage Vesiculectomy for Prostate Cancer Recurrence. Clin Genitourin Cancer. 2019 Jun; 17 (3):e536-e540 Epub 2019 Feb 06
    View PubMed
  126. Westerman ME, Sharma V, Bailey GC, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ. Impact of time from biopsy to surgery on complications, functional and oncologic outcomes following radical prostatectomy. Int Braz J Urol. 2019 May-Jun; 45 (3):468-477
    View PubMed
  127. Boswell TC, Sharma V, Westerman ME, Dean PG, Chow GK, Thompson RH, Leibovich BC, Boorjian SA. Frequency and Predictors of Renal Transplantation Among Patients Rendered Surgically Anephric for Sporadic Renal Cancer. Urology. 2019 Apr; 126:134-139 Epub 2019 Jan 12
    View PubMed
  128. Mahmoud A, Manka M, Lipworth R, Heslop D, Sharma V, Husmann D, Westerman ME. Alteplase Instillation for Upper Urinary Tract Clot Dissolution. J Endourol Case Rep. 2019; 5 (1):16-18 Epub 2019 Mar 16
    View PubMed
  129. Moschini M, Sharma V, Soligo M, Psutka S, Rangel L, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Karnes RJ. Heterogeneity of risk within Gleason 4 + 4, 4 + 5 and 5 + 4 prostate cancer. Scand J Urol. 2018 Oct - Dec; 52 (5-6):340-348 Epub 2019 Jan 02
    View PubMed
  130. Karnes RJ, Sharma V, Choeurng V, Ashab HA, Erho N, Alshalalfa M, Trock B, Ross A, Yousefi K, Tsai H, Zhao SG, Tosoian JJ, Haddad Z, Takhar M, Chang SL, Spratt DE, Abdollah F, Jenkins RB, Klein EA, Nguyen PL, Dicker AP, Den RB, Davicioni E, Feng FY, Lotan TL, Schaeffer EM. Development and Validation of a Prostate Cancer Genomic Signature that Predicts Early ADT Treatment Response Following Radical Prostatectomy. Clin Cancer Res. 2018 Aug 15; 24 (16):3908-3916 Epub 2018 May 14
    View PubMed
  131. Sharma V, Nehra A, Colicchia M, Westerman ME, Kawashima A, Froemming AT, Kwon ED, Mynderse LA, Karnes RJ. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy. Eur Urol. 2018 Jun; 73 (6):879-887 Epub 2017 Nov 28
    View PubMed
  132. Nguyen DP, Vertosick EA, Sharma V, Corradi RB, Vilaseca A, Takeda T, Sjoberg DD, Benfante N, Fine SW, Reuter VE, Scardino PT, Eastham JA, Karnes RJ, Touijer KA. Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy? J Urol. 2018 Jun; 199 (6):1502-1509 Epub 2018 Jan 04
    View PubMed
  133. Sharma V, Yousefi K, Haddad Z, Buerki C, Jenkins RB, Davicioni E, Karnes RJ. Gene Expression Correlates of Site-specific Metastasis Among Men With Lymph Node Positive Prostate Cancer Treated With Radical Prostatectomy: A Case Series. Urology. 2018 Feb; 112:29-32 Epub 2017 Oct 25
    View PubMed
  134. Sharma V, Dong H, Kwon E, Karnes RJ. Positive Pelvic Lymph Nodes in Prostate Cancer Harbor Immune Suppressor Cells To Impair Tumor-reactive T Cells. Eur Urol Focus. 2018 Jan; 4 (1):75-79 Epub 2016 Sept 21
    View PubMed
  135. Moschini M, Sharma V, Gandaglia G, Dell'Oglio P, Fossati N, Zaffuto E, Montorsi F, Briganti A, Karnes RJ. Long-term utility of adjuvant hormonal and radiation therapy for patients with seminal vesicle invasion at radical prostatectomy. BJU Int. 2017 Jul; 120 (1):69-75 Epub 2016 Nov 11
    View PubMed
  136. Colicchia M, Sharma V, Abdollah F, Briganti A, Jeffrey Karnes R. Therapeutic Value of Standard Versus Extended Pelvic Lymph Node Dissection During Radical Prostatectomy for High-Risk Prostate Cancer. Curr Urol Rep. 2017 Jul; 18 (7):51
    View PubMed
  137. Morlacco A, Sharma V, Viers BR, Rangel LJ, Carlson RE, Froemming AT, Karnes RJ. The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy. Eur Urol. 2017 May; 71 (5):701-704 Epub 2016 Aug 28
    View PubMed
  138. Westerman ME, Scales JA, Sharma V, Gearman DJ, Ingimarsson JP, Krambeck AE. The Effect of Anticoagulation on Bleeding-related Complications Following Ureteroscopy. Urology. 2017 Feb; 100:45-52 Epub 2016 Oct 05
    View PubMed
  139. Moses RA, Agarwal D, Raffin EP, Viers BR, Sharma V, Krambeck AE, Pais VM Jr. Postpercutaneous Nephrolithotomy Systemic Inflammatory Response Syndrome Is Not Associated With Unplanned Readmission. Urology. 2017 Feb; 100:33-37 Epub 2016 Sept 15
    View PubMed
  140. Westerman ME, Sharma V, Scales J, Gearman DJ, Ingimarsson JP, Krambeck AE. The Effect of Antiplatelet Agents on Bleeding-Related Complications After Ureteroscopy. J Endourol. 2016 Oct; 30 (10):1073-1078 Epub 2016 Aug 22
    View PubMed
  141. Moschini M, Sharma V, Zattoni F, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Kwon ED, Karnes RJ. Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup. J Urol. 2016 Jun; 195 (6):1773-8 Epub 2015 Dec 23
    View PubMed
  142. Moschini M, Karnes RJ, Sharma V, Gandaglia G, Fossati N, Dell'Oglio P, Cucchiara V, Capogrosso P, Shariat SF, Damiano R, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R. Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience. Eur J Surg Oncol. 2016 May; 42 (5):735-43 Epub 2016 Feb 18
    View PubMed
  143. Moschini M, Sharma V, Dell'oglio P, Cucchiara V, Gandaglia G, Cantiello F, Zattoni F, Pellucchi F, Briganti A, Damiano R, Montorsi F, Salonia A, Colombo R. Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy. BJU Int. 2016 Apr; 117: (4)604-10.
    View PubMed
  144. Moschini M, Sharma V, Zattoni F, Quevedo JF, Davis BJ, Kwon E, Karnes RJ. Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer After Radical Prostatectomy. Eur Urol. 2016 Jan; 69 (1):135-42 Epub 2015 Apr 10
    View PubMed
  145. Nason GJ, Walsh LG, Redmond CE, Kelly NP, McGuire BB, Sharma V, Kelly ME, Galvin DJ, Mulvin DW, Lennon GM, Quinlan DM, Flood HD, Giri SK. Comparative effectiveness of adrenal sparing radical nephrectomy and non-adrenal sparing radical nephrectomy in clear cell renal cell carcinoma: Observational study of survival outcomes. Can Urol Assoc J. 2015 Sep-Oct; 9 (9-10):E583-8 Epub 2015 Sept 09
    View PubMed
  146. Matulewicz RS, Sharma V, McGuire BB, Oberlin DT, Perry KT, Nadler RB. The effect of surgical duration of transurethral resection of bladder tumors on postoperative complications: An analysis of ACS NSQIP data. Urol Oncol. 2015 Aug; 33 (8):338.e19-24 Epub 2015 June 10
    View PubMed
  147. Choy J, Kashanian JA, Sharma V, Masson P, Dupree J, Le B, Brannigan RE. The men's health center: Disparities in gender specific health services among the top 50 "best hospitals" in America. Asian J Urol. 2015 Jul; 2 (3):170-174 Epub 2015 June 24
    View PubMed
  148. McGuire BB, Bhanji Y, Sharma V, Frainey BT, McClean M, Dong C, Rimar K, Perry KT, Nadler RB. Predicting Patients with Inadequate 24- or 48-Hour Urine Collections at Time of Metabolic Stone Evaluation. J Endourol. 2015 Jun; 29 (6):730-5 Epub 2015 Jan 07
    View PubMed
  149. Sharma V, Aggarwal A, McGuire BB, Rambachan A, Matulewicz RS, Kim JY, Nadler RB. Open vs Minimally Invasive Partial Nephrectomy: Assessing the Impact of BMI on Postoperative Outcomes in 3685 Cases from National Data. J Endourol. 2015 May; 29 (5):561-7 Epub 2014 Dec 15
    View PubMed
  150. Sharma V, Meeks JJ. Open conversion during minimally invasive radical prostatectomy: impact on perioperative complications and predictors from national data. J Urol. 2014 Dec; 192 (6):1657-62 Epub 2014 June 14
    View PubMed
  151. Sharma V, McGuire BB, Nadler RB. Implications of a 5-liter urinary bladder: inferior vena cava syndrome leading to bilateral pulmonary artery emboli. Urology. 2014 Jun; 83 (6):e11-2 Epub 2014 Apr 18
    View PubMed
  152. Sharma V, Zargaroff S, Sheth KR, Le BV, Dupree JM, Sandlow JI, Polackwich AS, Hedges JC, Fuchs EF, Goldstein M, Brannigan RE. Relating economic conditions to vasectomy and vasectomy reversal frequencies: a multi-institutional study. J Urol. 2014 Jun; 191 (6):1835-40 Epub 2014 Jan 11
    View PubMed
  153. Zargaroff S, Sharma V, Berhanu D, Pearl JA, Meeks JJ, Dupree JM, Le BV, Cashy J, McVary KT. National trends in the treatment of penile prosthesis infections by explantation alone vs. immediate salvage and reimplantation. J Sex Med. 2014 Apr; 11 (4):1078-1085 Epub 2014 Mar 13
    View PubMed
  154. Le B, Sharma V, Kim D, Dupree J, Maizels M. Routine neonatal circumcision: opportunities for improving residency training. J Pediatr Urol. 2013 Oct; 9 (5):605-8 Epub 2012 June 18
    View PubMed
  155. Sharma V, Le BV, Sheth KR, Zargaroff S, Dupree JM, Cashy J, Brannigan RE. Vasectomy demographics and postvasectomy desire for future children: results from a contemporary national survey. Fertil Steril. 2013 Jun; 99 (7):1880-5 Epub 2013 Mar 29
    View PubMed
  156. Sheth KR, Sharma V, Helfand BT, Cashy J, Smith K, Hedges JC, Kohler TS, Woodruff TK, Brannigan RE. Improved fertility preservation care for male patients with cancer after establishment of formalized oncofertility program. J Urol. 2012 Mar; 187: (3)979-86.
    View PubMed
  157. Zhang Q, Chen L, Helfand BT, Jang TL, Sharma V, Kozlowski J, Kuzel TM, Zhu LJ, Yang XJ, Javonovic B, Guo Y, Lonning S, Harper J, Teicher BA, Brendler C, Yu N, Catalona WJ, Lee C. TGF-beta regulates DNA methyltransferase expression in prostate cancer, correlates with aggressive capabilities, and predicts disease recurrence. PLoS One. 2011; 6 (9):e25168 Epub 2011 Sept 30
    View PubMed
  158. Le B, Mickelson J, Gossett D, Kim D, Stoltz RS, York S, Sharma V, Maizels M. Residency training in neonatal circumcision: a pilot study and needs assessment. J Urol. 2010 Oct; 184 (4 Suppl):1754-7 Epub 2010 Aug 21
    View PubMed
  159. Melquist J, Sharma V, Sciullo D, McCaffrey H, Khan SA. Current diagnosis and management of syringocele: a review. Int Braz J Urol. 2010 Jan-Feb; 36 (1):3-9
    View PubMed